Fundz

Alkem Medtech to acquire majority stake in Occlutech

PRIVATEJun 29, 2026

Acquiring Company

Alkem Medtech

Acquired Company

Occlutech Holding AG

GujaratSwitzerlandManufacturingBiotechnologyHealth CareMedicalMedical DeviceManufacturingBiotechnologyHealth CareMedical Device

Description

Alkem Medtech Private Limited has signed an agreement to acquire a 51%-55% stake in Occlutech Holding AG. This acquisition, aimed at gaining a controlling interest, was formalized on June 26, 2026. The deal modifies the original Share Purchase Agreement from March 2026. This strategic move is part of Alkem Laboratories' efforts to expand its market reach.

Who to call at Alkem Medtech, and when

When Alkem Medtech changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Alkem Medtech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alkem Medtech, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alkem Medtech

Location

Gujarat, India

About

Alkem Medtech is a subsidiary of Alkem Laboratories focusing on medical technology. The company is dedicated to expanding its presence in the medtech industry through strategic acquisitions. It aims to innovate and provide advanced healthcare solutions. Alkem Medtech operates under the larger umbrella of Alkem Laboratories.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alkem Medtech makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kaustav
Senior decision-maker at this company
••••••••@••••••••

See Kaustav's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Alkem Medtech's next move

Learn about Strategic plan

Frequently asked

Who acquired Occlutech Holding AG?

Occlutech Holding AG was acquired by Alkem Medtech, based in Gujarat. The deal was reported on June 29, 2026. Alkem Medtech is a subsidiary of Alkem Laboratories focusing on medical technology. The company is dedicated to expanding its presence in the medtech industry through strategic acquisitions. Alkem Medtech is privately held and operates in Manufacturing.

When did Alkem Medtech acquire Occlutech Holding AG?

Alkem Medtech's acquisition of Occlutech Holding AG was reported on June 29, 2026. Alkem Medtech Private Limited has signed an agreement to acquire a 51%-55% stake in Occlutech Holding AG. This acquisition, aimed at gaining a controlling interest, was formalized on June 26, 2026. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Occlutech Holding AG do?

Occlutech specializes in minimally invasive cardiac implants. Founded in 2003, it develops devices for treating congenital heart disease and other cardiovascular conditions. It is a major player in the European market for these devices. It is privately held, operating in Manufacturing, and is based in Switzerland.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.